Advertisement
UK markets close in 2 hours 23 minutes
  • FTSE 100

    8,116.32
    +37.46 (+0.46%)
     
  • FTSE 250

    19,787.77
    +185.79 (+0.95%)
     
  • AIM

    754.78
    +1.66 (+0.22%)
     
  • GBP/EUR

    1.1672
    +0.0016 (+0.14%)
     
  • GBP/USD

    1.2512
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    51,296.29
    +807.99 (+1.60%)
     
  • CMC Crypto 200

    1,387.51
    -9.02 (-0.65%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CRUDE OIL

    84.39
    +0.82 (+0.98%)
     
  • GOLD FUTURES

    2,355.30
    +12.80 (+0.55%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,051.61
    +134.33 (+0.75%)
     
  • CAC 40

    8,047.44
    +30.79 (+0.38%)
     

Siemens, regulator deny China bribery report

SHANGHAI, May 5 (Reuters) - Siemens AG (Xetra: SIEC.DE - news) and China's State Administration for Industry and Commerce (SAIC (Shanghai: 600848.SS - news) ), a competition regulator, denied a Reuters report that the SAIC investigated the German group's healthcare unit and its dealers for "commercial bribery".

"The SAIC has not launched a commercial bribery investigation into Siemens Healthcare Unit," a spokesperson for the regulator said in a statement on its website.

Senior Germany-based Siemens (BSE: SIEMENS4.BO - news) spokesman Matthias Kraemer said in response to the Reuters article: "The fact is, a branch of Administration of Industry and Commerce (AIC) in Shanghai is looking into Siemens Healthcare's Laboratory Diagnostics marketing and business model, which is common worldwide in the industry."

"Contrary to the recent media reports, the probe is neither corruption-related nor related to any personal benefits to individuals," he said, adding Siemens was working closely with AIC to dispel its concerns and "expects to resolve the matter in the near future." (Reporting by Adam Jourdan and Engen Tham; Editing by Ian Geoghegan)